#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with locally advanced cervical cancer
1. Progression-free survival at 24 months was higher in the pembrolizumab versus...
Read MoreMay 14, 2024
1. Progression-free survival at 24 months was higher in the pembrolizumab versus...
Read MoreMay 3, 2024
Timely initiation of vaginal dilation therapy improved vaginal health and sexual well-being in patients who received cervical cancer treatment.
Read MoreMay 1, 2024
1. Progression-free survival at 24 months was higher in the pembrolizumab versus...
Read MoreMar 26, 2024
MONDAY, March 25, 2024 (HealthDay News) — Up-to-date cervical cancer screening is lower in...
Read MoreMar 12, 2024
The following is a summary of “An MRI radiomics-based model for prediction of pelvic lymph node...
Read MoreMar 7, 2024
Phytochemicals have become a growing source of alternative medicine in developing countries due to the poor prognosis, high cost of conventional pharmaceuticals, and undesirable effects associated with mainstream cancer...
Read MoreMar 4, 2024
There is an increased risk of cervical cancer among women living with HIV. While studies have long examined the association between cervical cancer among women with HIV, no study has examined the time taken for women with HIV to...
Read MoreMar 1, 2024
THURSDAY, Feb. 29, 2024 (HealthDay News) — For patients with low-risk cervical cancer,...
Read MoreFeb 29, 2024
The following is a summary of “Practice patterns and complications of hysterectomy for...
Read MoreFeb 12, 2024
Cervical cancer (CC) is a common gynecologic malignancy, accounting for a significant proportion of women death worldwide. Human papillomavirus (HPV) infection is one of the major etiological causes leading to CC onset; however,...
Read MoreFeb 9, 2024
1. The Atezolizumab group demonstrated significantly greater progression-free and overall survival...
Read MoreFeb 1, 2024
1. The Atezolizumab group demonstrated significantly greater progression-free and overall survival...
Read MoreJan 31, 2024
TUESDAY, Jan. 30, 2024 (HealthDay News) — The incidence and mortality of cervical cancer...
Read MoreJan 29, 2024
Cervical cancer is one of the most common types of female cancers worldwide. IL-29 is an interesting cytokine in the IFNλ family. Its role in the pathogenesis of neoplasia is complicated and has been studied in other cancers,...
Read MoreJan 23, 2024
The following is a summary of “Practice Patterns and Complications of Hysterectomy for Invasive...
Read MoreDec 11, 2023
In recent years fertility-sparing treatments are increasingly developing in patients with early stage cervical cancer. Among these, trachelectomy represents a milestone with a wide range of surgical approaches, evidence of...
Read MoreDec 1, 2023
THURSDAY, Nov. 30, 2023 (HealthDay News) — Undergoing active surveillance for cervical...
Read MoreDec 1, 2023
THURSDAY, Nov. 30, 2023 (HealthDay News) — For individuals who are due or overdue for...
Read MoreNov 20, 2023
The following is a summary of “Survival associated with extent of radical hysterectomy in...
Read MoreNov 13, 2023
Cervical cancer (CC) is a gynecological neoplasm with the highest incidence rate, primarily...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.